Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation

CC Chu, N Ali, P Karagiannis, P Di Meglio… - Journal of Experimental …, 2012 - rupress.org
CC Chu, N Ali, P Karagiannis, P Di Meglio, A Skowera, L Napolitano, G Barinaga, K Grys…
Journal of Experimental Medicine, 2012rupress.org
Human skin immune homeostasis, and its regulation by specialized subsets of tissue-
residing immune sentinels, is poorly understood. In this study, we identify an
immunoregulatory tissue-resident dendritic cell (DC) in the dermis of human skin that is
characterized by surface expression of CD141, CD14, and constitutive IL-10 secretion
(CD141+ DDCs). CD141+ DDCs possess lymph node migratory capacity, induce T cell
hyporesponsiveness, cross-present self-antigens to autoreactive T cells, and induce potent …
Human skin immune homeostasis, and its regulation by specialized subsets of tissue-residing immune sentinels, is poorly understood. In this study, we identify an immunoregulatory tissue-resident dendritic cell (DC) in the dermis of human skin that is characterized by surface expression of CD141, CD14, and constitutive IL-10 secretion (CD141+ DDCs). CD141+ DDCs possess lymph node migratory capacity, induce T cell hyporesponsiveness, cross-present self-antigens to autoreactive T cells, and induce potent regulatory T cells that inhibit skin inflammation. Vitamin D3 (VitD3) promotes certain phenotypic and functional properties of tissue-resident CD141+ DDCs from human blood DCs. These CD141+ DDC-like cells can be generated in vitro and, once transferred in vivo, have the capacity to inhibit xeno-graft versus host disease and tumor alloimmunity. These findings suggest that CD141+ DDCs play an essential role in the maintenance of skin homeostasis and in the regulation of both systemic and tumor alloimmunity. Finally, VitD3-induced CD141+ DDC-like cells have potential clinical use for their capacity to induce immune tolerance.
rupress.org